ADVB — Advanced Biomed Inc.

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 1941029 ·
Last close
$2.10
Market Cap
$3.47M
52W High
$24.23
52W Low
$1.80
ADV30
66,396
Next earnings
—
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. It offers A+Pre, a device that prepares blood samples for testing; the AC-1000, a device that separates cancer cells from the rest of the blood; A+SCDrop, a device that isolates individual cells; and A+CellScan, a device that stains and automatically counts cancer cells. The company provides developed dye kits used to identify different types of cancer cells. It also offers FinTruth financial verification agent platform, an enterprise AI financial verification platform designed to compare and verify financial analysis and AI-generated financial content against underlying source documents and financial rules, and to produce source-traceable and auditable results. The company was founded in 2014 and is based in Tsuen Wan, Hong Kong.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 127,637 — -4,829,689 694,999 13,750,716 385,535 1,473,989
Mar 2026 0 — -519,836 -488,942 10,646,324 2,602,697 1,436,587
Dec 2025 0 — -396,642 6,857,921 10,850,712 2,604,666 1,369,070
Sep 2025 0 — -523,914 -386,901 6,242,970 2,656,519 3,238,846

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-961,341
Investing CF
$-2,581,850
Financing CF
$1,326,215
CapEx
$-18,156
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$4.07
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-12,555,967
Inventory
$8,835
Receivables
$13,361,977
ST Investments
—
EBIT TTM
$-6,353,500
Pretax Income TTM
$-6,390,703
Interest Exp TTM
$112
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$127,637
EBITDA
$-6,174,261
Free Cash Flow
$-12,022,238
Enterprise Value
$6,161,240
Total Cash
$385,535
Total Debt
$1,078,215
Shares Out
1,652,133
Trailing EPS
$-5.00
Book Value
$7.43
ROE
-79.5%
ROA
-21.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 127,637 -6,141,042 6,677,077 13,750,716 1,473,989 12,276,727 -1,946,943
Jun 2025 — — — — — — —
Jun 2024 0 -2,541,572 -2,782,278 4,460,247 2,796,989 1,663,258 -2,126,340
Jun 2023 0 -3,071,223 -3,732,777 4,599,977 3,294,389 1,305,588 -2,963,625
Jun 2022 0 — -4,027,722 — — 3,491,596 -741,450

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$10,646,324
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
MGRX MANGOCEUTICALS, INC. $3.45M $0.16 —
ACON Aclarion, Inc. $3.95M $1.37 —
HLYK HealthLynked Corp $2.51M $0.85 —
BGLC BioNexus Gene Lab Corp $2.25M $0.77 —
BICX BioCorRx Inc. $6.22M $0.21 —

News headlines (Yahoo Finance, 1h cache)

Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
2026-02-18 12:00 · Yahoo
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
2026-02-13 13:00 · Yahoo
Advanced Biomed sells Hong Kong subsidiary for $23,000
2025-12-31 15:25 · Yahoo
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
2025-12-30 15:17 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.